Protagenic Therapeutics Q2 EPS $(0.11) Down From $(0.06) YoY

Protagenic Therapeutics (NASDAQ:PTIX) reported quarterly losses of $(0.11) per share. This is a 83.33 percent decrease over losses of $(0.06) per share from the same period last year.

Protagenic Therapeutics (NASDAQ:PTIX) reported quarterly losses of $(0.11) per share. This is a 83.33 percent decrease over losses of $(0.06) per share from the same period last year.

Total
0
Shares
Related Posts